Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: poor quality (76), poor (225), cheap (4)

ImatinibChronic

Description: Chemotherapy Protocol Chronic Myeloid Leukaemia Regimen IMATINIB (chronic phase) • CML – Imatinib (chronic phase) Indication • As the pr
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/ImatinibChronic.pdf

ImatinibAccelerated

Description: Chemotherapy Protocol Chronic Myeloid Leukaemia Regimen IMATINIB (accelerated phase) • CML - Imatinib (accelerated phase) Indication • As the p
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/ImatinibAccelerated.pdf

Chlorambucil_2_Obinutuzumab

Description: Chemotherapy Protocol Chronic Lymphocytic Leukaemia Chlorambucil (2 day)-Obinutuzumab (6 cycles) Regimen • CLL – Chlorambucil (2 day)-Obinutu
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/Chlorambucil-2-Obinutuzumab.pdf

Chlorambucil_14_Obinutuzumab

Description: Chemotherapy Protocol Chronic Lymphocytic Leukaemia Chlorambucil (14 day)-Obinutuzumab (6 cycles) Regimen • CLL – Chlorambucil (14 day)-Obinut
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/Chlorambucil-14-Obinutuzumab.pdf

Having a DXA scan - patient information

Description: This factsheet explains what a DXA scan is, what the scan involves and how to prepare for your appointment.
Url: /Media/UHS-website-2019/Patientinformation/Scansandx-rays/Having-a-DXA-scan-3198-PIL.pdf

Finance and Performance Reports 2020-21 Month 4 July 2020

Description: 2020/21 Finance Report - Month 4 Report to: Board of Directors and Finance & Investment Committee Au
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2020/finance-and-performance-reports-2020-21-month-4-july-2020-1.pdf

Aria ePrescribing v13.6 MR1.2 user training guide

Description: Aria E-Prescribing v13.6 MR1.2 User Training Guide Every effort has been made to ensure that the material
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/User-guides/Aria-ePrescribing-v13.6-MR1.2-user-training-guide.pdf

Obinutuzumab_maintenance

Description: Chemotherapy Protocol Non-Hodgkin Lymphoma Obinutuzumab (Maintenance) Regimen • NHL – Obinutuzumab (Maintenance) Indication • Obinutuzumab in combination with bendamustine followed by ob
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Obinutuzumab-maintenance.pdf

MyelomaPAD-Bortezomib(SC)DexamethasoneDoxorubicinVer1

Description: Chemotherapy Protocol MULTIPLE MYELOMA PAD (SC)-BORTEZOMIB (SC)-DEXAMETHASONE-DOXORUBICIN Regimen Multiple Myeloma – PAD (SC)-Bortezomib (SC)-Dexamethasone
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/MyelomaPAD-BortezomibSCDexamethasoneDoxorubicinVer1.pdf

MyelomaPAD-Bortezomib(IV)DexamethasoneDoxorubicinVer1

Description: Chemotherapy Protocol MULTIPLE MYELOMA PAD (IV)-BORTEZOMIB (IV)-DEXAMETHASONE-DOXORUBICIN Regimen Multiple Myeloma – PAD (IV)-Bortezomib (IV)-Dexamethasone
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/MyelomaPAD-BortezomibIVDexamethasoneDoxorubicinVer1.pdf

61 to 70 of 266

Previous … 5 6 7 8 9 … Next